Diary - News
All news Imaxio and AJ Biologics announce the execution of a collaboration agreement to extend the commercialisation of Imaxio’s leptospirosis vaccine in Malaysia
Imaxio, a biotech company specialising in immunology, announces today the execution of a license agreement with AJ Biologics, a Malaysian company dedicated to vaccine manufacturing and commercialization, as part of the company’s strategy to extend the distribution of Imaxio’s leptospirosis vaccine in Malaysia.
